Literature DB >> 8822016

Psychological morbidity and route of administration among amphetamine users in Sydney, Australia.

W Hall1, J Hando, S Darke, J Ross.   

Abstract

A sample of 301 amphetamine users were interviewed about their experiences of psychological symptoms prior to, and subsequent to, their initiation of amphetamine use. Psychological morbidity was common, with 44% scoring greater than a conservative cut-off of 8 on the General Health Questionnaire. The most commonly reported symptoms subsequent to the onset of amphetamine use were depression (79%), anxiety (76%), paranoia (52%), hallucinations (46%) and violent behaviour (44%). All these symptoms increased in prevalence after the onset of amphetamine use. Route and frequency of amphetamine administration were significant independent predictors of overall psychological morbidity, while route of administration was related to the experience of hallucinations, violent behaviour and paranoia. The avoidance of injection as a route of administration and the use of amphetamines less than weekly are recommended as steps that users can take to reduce the psychological sequelae of amphetamine use.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8822016     DOI: 10.1046/j.1360-0443.1996.9118110.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  25 in total

1.  Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers.

Authors:  Matthew G Kirkpatrick; Nicholas I Goldenson; Nahel Kapadia; Christopher W Kahler; Harriet de Wit; Robert M Swift; John E McGeary; Steve Sussman; Adam M Leventhal
Journal:  Psychopharmacology (Berl)       Date:  2015-10-02       Impact factor: 4.530

2.  Differences in cortical activity between methamphetamine-dependent and healthy individuals performing a facial affect matching task.

Authors:  Doris E Payer; Matthew D Lieberman; John R Monterosso; Jiansong Xu; Timothy W Fong; Edythe D London
Journal:  Drug Alcohol Depend       Date:  2007-10-26       Impact factor: 4.492

Review 3.  Neurocognitive effects of methamphetamine: a critical review and meta-analysis.

Authors:  J Cobb Scott; Steven Paul Woods; Georg E Matt; Rachel A Meyer; Robert K Heaton; J Hampton Atkinson; Igor Grant
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

4.  Injection methamphetamine use is associated with an increased risk of attempted suicide: a prospective cohort study.

Authors:  Brandon D L Marshall; Sandro Galea; Evan Wood; Thomas Kerr
Journal:  Drug Alcohol Depend       Date:  2011-06-14       Impact factor: 4.492

Review 5.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Neurol Clin       Date:  2011-06-24       Impact factor: 3.806

6.  Psychiatric comorbidity in methamphetamine dependence.

Authors:  Ruth Salo; Keith Flower; Anousheh Kielstein; Martin H Leamon; Thomas E Nordahl; Gantt P Galloway
Journal:  Psychiatry Res       Date:  2010-11-04       Impact factor: 3.222

7.  Restricted psychological horizon in active methamphetamine users: future, past, probability, and social discounting.

Authors:  Richard Yi; Anne E Carter; Reid D Landes
Journal:  Behav Pharmacol       Date:  2012-08       Impact factor: 2.293

8.  Causes of death of patients with methamphetamine dependence: a record-linkage study.

Authors:  Chian-Jue Kuo; Ya-Tang Liao; Wei J Chen; Shang-Ying Tsai; Shih-Ku Lin; Chiao-Chicy Chen
Journal:  Drug Alcohol Rev       Date:  2010-10-18

9.  Clinical features of methamphetamine-induced paranoia and preliminary genetic association with DBH-1021C→T in a Thai treatment cohort.

Authors:  Rasmon Kalayasiri; Viroj Verachai; Joel Gelernter; Apiwat Mutirangura; Robert T Malison
Journal:  Addiction       Date:  2014-03-17       Impact factor: 6.526

Review 10.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Psychiatr Clin North Am       Date:  2013-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.